By Notice dated December 21, 2004, and published in the Federal Register on January 4, 2005, (70 FR 391), Houba, Inc., P.O. Box 190, 16235 State Road 17, Culver, Indiana 46511, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II; and by letter dated October 1, 2004, to modify its name to Acura Pharmaceutical Technologies, Inc., and change the address by removing the P.O. Box 190.
The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Start Printed Page 17262
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Houba, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Houba, Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.Start Signature
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-6698 Filed 4-4-05; 8:45 am]
BILLING CODE 4410-09-P